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  ABSTRACT 	  
Background: Ischemic heart disease is one of the leading causes of death globally. This 
thesis explores endogenous mechanisms protecting against myocardial ischemia in context 
of epigenetics (changes in gene activity not caused by changes in DNA sequences). 
Epigenetic regulation of vascular thromboprotective mechanism was assessed, as well as the 
capacity of extracellular vesicle (EV) involvement in mediating epigenetic changes related to 
cardioprotection in ischemic preconditioning (IPC).   
 
Aims: The aim of Papers I and II was to evaluate if histone deacetylase inhibition, by 
valproic acid (VPA) treatment, increases stimulated tissue plasminogen activator (t-PA) 
release capacity and affects plasminogen activator inhibitor-1 (PAI-1) levels in vivo, in 
healthy large animals and in an atherosclerotic cohort. The aim of Papers III and IV was to 
assess if coronary venous EV genetic content is affected by myocardial IPC in vivo. 
 
Methods: In a porcine myocardial ischemia model transcoronary t-PA release was 
measured and compared between VPA treated (n=12) and untreated animals (n=10). In the 
clinical cross-over study (n=16), the perfused forearm model was used to measure single 
and repeated t-PA release capacity by isoprenaline provocation with and without VPA. 
PAI-1 was also measured. In a porcine model, EV were collected from coronary venous 
blood before and after myocardial IPC. The EV were isolated by differential 
ultracentrifugation and the preparation was evaluated by western blot, electron microscopy 
and nanoparticle tracking analysis. Changes in EV genetic content after IPC were identified 
by microarray and DNA sequencing.   
 
Results: Animals treated with VPA demonstrated a significantly higher cumulative 
transcoronary t-PA release compared to controls. In the clinical study, VPA treatment 
resulted in increased cumulative t-PA release capacity during repeated isoprenaline 
stimulation, though there was no difference when comparing single stimulation sequences. 
Levels of PAI-1 were reduced after VPA treatment. Among 11678 mRNA sequences 
detected in EV, about 10% were up or down regulated after IPC. Among these, over half 
were increased, including several with association to cardioprotection and IPC. DNA 
fragments, representing all porcine chromosomes, were identified in EV. The DNA content 
in EV changed after myocardial IPC.  
 
Conclusions: Intervention of HDACi, by VPA treatment, may improve actions of the 
fibrinolytic system by enhancing t-PA release capacity and reducing PAI-1 levels in vivo. In a 
future perspective, this may have clinical relevance as novel means of preventive strategies 
for ischemic heart disease. Myocardial IPC influences the composition of EV genetic 
content, including increases in gene transcripts associated to cardioprotecion. This may 
reflect a biological relevance of EV in delivering cardioprotective signals in IPC, although 
further studies are necessary to confirm such connection.  	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